Jyothy Labs Limited has announced a board meeting scheduled for Monday, May 4, 2026, to review its financial performance for the fourth quarter of fiscal year 2026 and consider dividend recommendations. The company has issued formal intimation to stock exchanges in compliance with regulatory requirements on April 27, 2026.

Official Communication Details

The board meeting intimation was formally communicated to both BSE Limited and National Stock Exchange of India Limited through official correspondence dated April 27, 2026. The communication was digitally signed by Shreyas Trivedi, Head – Legal & Company Secretary, at 12:06:07 +05'30' on April 27, 2026.

Meeting Agenda and Regulatory Compliance

The board meeting has been scheduled pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting will address two primary matters of significant importance to shareholders and investors.

Corporate Information

Jyothy Labs Limited operates from 'Ujala House', Ramkrishna Mandir Road, Kondivita, Andheri (East), Mumbai 400059. The company maintains transparency by making this information available on its official website at www.jyothylabs.com , in addition to the formal stock exchange notifications. The company's CIN is L24240MH1992PLC128651.

Regulatory Framework

This announcement follows standard corporate governance practices under SEBI regulations, which mandate listed companies to provide advance notice of board meetings where financial results and dividend decisions are to be considered. The company has requested stock exchanges to disseminate this information for investor awareness and record-keeping purposes.

Jyothy Labs Limited has formally notified stock exchanges that it does not qualify as a Large Corporate entity for the Financial Year ended March 31, 2026, under the Securities and Exchange Board of India (SEBI) regulatory framework. The company submitted its mandatory disclosure to both BSE Limited and the National Stock Exchange of India Limited on April 8, 2026.

Regulatory Compliance Framework

The disclosure was made pursuant to SEBI Operational Circular no. SEBI/HO/DDHS/P/CIR/2021/613 dated August 10, 2021. According to the company's statement, it does not fulfill the criteria specified in para 1.2 of Chapter XII of the SEBI Operational Circular, thereby exempting it from Large Corporate classification requirements.

Financial Position and Credit Rating

The company's financial disclosure reveals key metrics that support its non-Large Corporate status:

Corporate Information

Jyothy Labs Limited, incorporated with CIN L24240MH1992PLC128651, is headquartered at Ujala House, Ramkrishna Mandir Road, Kondivita, Andheri (East), Mumbai. The company's disclosure was executed by two key officials:

• Shreyas Trivedi, Head – Legal & Company Secretary
• Pawan Kumar Agarwal, Chief Financial Officer

Regulatory Significance

The Large Corporate framework under SEBI regulations requires entities meeting specific criteria to maintain certain borrowing thresholds and compliance standards. Companies not meeting these criteria must file initial disclosures confirming their non-applicability status. Jyothy Labs' nil outstanding borrowings position clearly places it outside the Large Corporate classification parameters.

The disclosure document was digitally signed and submitted with complete contact details of responsible officers, ensuring transparency and accountability in regulatory compliance. This filing demonstrates the company's commitment to maintaining proper corporate governance standards and timely regulatory disclosures.